PNC FINANCIAL SERVICES GROUP, INC. - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$44,374
-21.6%
8,142
-3.4%
0.00%
Q2 2023$56,579
-6.4%
8,432
+23.2%
0.00%
Q1 2023$60,442
+14.9%
6,845
-0.6%
0.00%
Q4 2022$52,609
-17.8%
6,886
-22.4%
0.00%
Q3 2022$64,000
+100.0%
8,876
+127.6%
0.00%
Q2 2022$32,000
-56.2%
3,899
-26.3%
0.00%
Q1 2022$73,000
+37.7%
5,293
+176.7%
0.00%
Q4 2021$53,000
-70.4%
1,913
-63.5%
0.00%
Q3 2021$179,000
-43.2%
5,246
-32.0%
0.00%
Q2 2021$315,000
-19.8%
7,718
-20.9%
0.00%
Q1 2021$393,000
-33.2%
9,760
-1.7%
0.00%
-100.0%
Q4 2020$588,000
+90.3%
9,924
+56.0%
0.00%
Q3 2020$309,000
-4.0%
6,362
-4.1%
0.00%
Q2 2020$322,000
+1688.9%
6,635
+922.3%
0.00%
Q1 2020$18,000
-5.3%
649
+1.7%
0.00%
Q4 2019$19,000
-5.0%
638
-0.5%
0.00%
Q3 2019$20,0006410.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders